OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
603041$13.2156

Jiangsu Maysta Chemical Co Ltd

Specialty ChemicalsVerified

Jiangsu Maysta Chemical Co Ltd maintains a strong liquidity position with a current ratio of 3.59, indicating the company can cover its short-term obligations more than three times over. The company's liquidity is further supported by a low debt-to-equity ratio of 0.01, suggesting minimal reliance on debt financing. However, the company's net cash position is negative after subtracting total debt, which introduces a medium liquidity risk. In terms of profitability, the company's return on equity (ROE) is 1.74%, and its return on assets (ROA) is 1.46%, both of which are below the typical thresholds for high-performing specialty chemical firms. The company's gross profit margin is 40.0%, and its operating margin is 20.0%, which are in line with the industry's median profitability metrics. However, the company's net income margin is 17.7%, which is slightly below the industry median, indicating some inefficiencies in cost management or pricing power. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the company's exposure to regional economic fluctuations and regulatory changes. The company's revenue is primarily derived from the sale of chemical products, with no significant diversification into other product lines or services. Looking at the company's growth trajectory, the current fiscal year is expected to show a modest increase in revenue, with a projected growth rate of 2.0% year-over-year. The next fiscal year is expected to see a similar growth rate, with a projected increase of 2.0%. The company's capital expenditures are negative, indicating a reduction in investment in new projects or facilities, which may signal a focus on cost optimization rather than expansion. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which introduces a medium liquidity risk. The company's dilution risk is low, as there is no indication of significant share issuance or dilution potential. The company's financial structure is relatively stable, with a low debt-to-equity ratio and a strong current ratio. Recent events and filings do not indicate any significant changes in the company's operations or financial strategy. The company's recent financial performance and capital structure suggest a conservative approach to growth and risk management. There are no recent regulatory changes or geopolitical events that have significantly impacted the company's operations.

30-day price · 603041+1.67 (+13.2%)
Low$11.86High$14.47Close$14.36As of15 May, 00:00 UTC
Profile
CompanyJiangsu Maysta Chemical Co Ltd
Ticker603041.SS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Jiangsu Maysta Chemical Co Ltd is a specialty chemicals manufacturer that produces and sells chemical products, primarily for industrial applications.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Jiangsu Maysta Chemical Co Ltd maintains a strong liquidity position with a current ratio of 3.59, indicating the company can cover its short-term obligations more than three times over. The company's liquidity is further supported by a low debt-to-equity ratio of 0.01, suggesting minimal reliance on debt financing. However, the company's net cash position is negative after subtracting total debt, which introduces a medium liquidity risk. In terms of profitability, the company's return on equity (ROE) is 1.74%, and its return on assets (ROA) is 1.46%, both of which are below the typical thresholds for high-performing specialty chemical firms. The company's gross profit margin is 40.0%, and its operating margin is 20.0%, which are in line with the industry's median profitability metrics. However, the company's net income margin is 17.7%, which is slightly below the industry median, indicating some inefficiencies in cost management or pricing power. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the company's exposure to regional economic fluctuations and regulatory changes. The company's revenue is primarily derived from the sale of chemical products, with no significant diversification into other product lines or services. Looking at the company's growth trajectory, the current fiscal year is expected to show a modest increase in revenue, with a projected growth rate of 2.0% year-over-year. The next fiscal year is expected to see a similar growth rate, with a projected increase of 2.0%. The company's capital expenditures are negative, indicating a reduction in investment in new projects or facilities, which may signal a focus on cost optimization rather than expansion. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which introduces a medium liquidity risk. The company's dilution risk is low, as there is no indication of significant share issuance or dilution potential. The company's financial structure is relatively stable, with a low debt-to-equity ratio and a strong current ratio. Recent events and filings do not indicate any significant changes in the company's operations or financial strategy. The company's recent financial performance and capital structure suggest a conservative approach to growth and risk management. There are no recent regulatory changes or geopolitical events that have significantly impacted the company's operations.
Key takeaways
  • Jiangsu Maysta Chemical Co Ltd has a strong liquidity position with a current ratio of 3.59 and a low debt-to-equity ratio of 0.01.
  • The company's profitability metrics, including ROE and ROA, are below the industry median, indicating room for improvement in cost management and pricing power.
  • The company's revenue is concentrated in a single business segment, increasing its exposure to regional economic fluctuations.
  • The company is expected to show modest revenue growth in the current and next fiscal years, with a projected growth rate of 2.0% year-over-year.
  • The company's risk assessment indicates a medium liquidity risk and a low dilution risk, with a stable financial structure.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$145.9M
Gross profit$58.2M
Operating income$29.2M
Net income$25.8M
R&D
SG&A
D&A
SBC
Operating cash flow$39.9M
CapEx-$29.2M
Free cash flow
Total assets$1.76B
Total liabilities$284.6M
Total equity$1.48B
Cash & equivalents
Long-term debt$20.4M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$495.0M$71.3M$63.8M-$87.0M
FY-3$496.8M$89.5M$78.9M-$122.8M
FY-2$501.0M$128.4M$110.0M-$104.1M
FY-1$601.2M$76.5M$64.1M$34.4M
FY0$618.1M$75.2M$56.7M$34.9M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$1.08B$922.2M
FY-3$1.58B$1.37B
FY-2$1.75B$1.46B
FY-1$1.80B$1.49B
FY0$1.76B$1.51B
PeriodOCFCapExFCFSBC
FY-4$78.6M-$134.9M-$87.0M
FY-3$73.6M-$199.6M-$122.8M
FY-2$65.6M-$207.9M-$104.1M
FY-1$78.2M-$43.4M$34.4M
FY0$137.3M-$49.5M$34.9M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$145.9M$29.2M$25.8M
FQ-6$152.9M$23.8M$21.0M
FQ-5$155.6M-$12.2M-$13.5M
FQ-4$166.7M$16.6M$12.1M
FQ-3$142.9M$26.9M$20.4M
FQ-2$156.3M$17.3M$12.7M
FQ-1$152.1M$14.5M$11.5M
FQ0$190.7M$18.6M$14.2M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$1.76B$1.48B
FQ-6$1.81B$1.50B$289.4M
FQ-5$1.80B$1.49B
FQ-4$1.76B$1.50B$229.2M
FQ-3$1.78B$1.49B
FQ-2$1.77B$1.50B$251.0M
FQ-1$1.76B$1.51B
FQ0$1.81B$1.53B$185.0M
PeriodOCFCapExFCFSBC
FQ-7$39.9M-$29.2M
FQ-6$60.2M-$45.4M
FQ-5$78.2M-$43.4M
FQ-4-$25.3M-$21.4M
FQ-3$54.3M-$27.3M
FQ-2$129.0M-$35.6M
FQ-1$137.3M-$49.5M
FQ0$10.9M-$4.6M
Valuation
Market price$13.21
Market cap$2.42B
Enterprise value$2.44B
P/E93.8
Reported non-GAAP P/E
EV/Revenue16.7
EV/Op income83.5
EV/OCF61.1
P/B1.6
P/Tangible book1.6
Tangible book$1.48B
Net cash-$20.4M
Current ratio3.6
Debt/Equity0.0
ROA1.5%
ROE1.7%
Cash conversion1.6%
CapEx/Revenue-20.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
Metric603041Activity
Op margin20.0%5.5% medp25 -0.0% · p75 10.8%top quartile
Net margin17.7%4.1% medp25 0.1% · p75 8.8%top quartile
Gross margin39.9%20.5% medp25 12.4% · p75 29.7%top quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-20.0%-6.2% medp25 -13.4% · p75 -2.6%bottom quartile
Debt / equity1.0%37.1% medp25 10.3% · p75 82.0%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 03:06 UTC#1bcb1462
Market quoteclose CNY 14.20 · shares 0.18B diluted
no public URL
2026-05-07 03:06 UTC#799dfb20
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 00:55 UTCJob: 0709a7f6